Methods of screening for toxicity of test compounds

Details for Australian Patent Application No. 2002364692 (hide)

Owner Bristol-Myers Squibb Company

Inventors Moulin, Frederic; Durham, Stephen K; Flint, Oliver

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002364692

PCT Number PCT/US02/34894

PCT Pub. Number WO2003/050297

Priority 60/336,509 31.10.01 US

Filing date 31 October 2002

Wipo publication date 23 June 2003

Acceptance publication date 23 November 2006

International Classifications

C12Q 1/26 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving oxidoreductase

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

17 July 2003 Complete Application Filed

  Priority application(s): 60/336,509 31.10.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002364692

23 November 2006 Application Accepted

  Published as AU-B-2002364692

22 March 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002364693-RADIAL POWER MEGASONIC TRANSDUCER

2002364691-ISOLATED HUMAN KINASE PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN KINASE PROTEINS, AND USES THEREOF